Yingqian Zhang

发表

D-1553 (garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients with Non-Small Cell Lung Cancer: Phase I Study Results.

Yanqiu Zhao, N. Yang, Yiping Zhang, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.